Grifols SA - ADR - Level III Live Stock Price Today, Share Analysis and Chart

Name: Grifols SA - ADR - Level III: Is Infosys Ltd. worth buying?
Item: Grifols SA - ADR - Level III
Rating: 2.16341675
Author: Trendlyne DVM scores

about

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once i...

10.66 0.01 (0.09%)

Near 52W High of $11.14

751.6K

XNAS Volume

XNAS 08 Aug, 2025 5:30 PM (EDT)

Dividend

Grifols SA - ADR - Level III has an upcoming dividend of $0.17 per share due on 12 Aug 2025 See details

Not Eligible

Expensive Valuation

24.7 / 100

Technically Moderately Bullish

61.9 / 100

1Yr Price target upside is 14%

2 analysts

Grifols SA - ADR - Level III Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..